Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.52 |
| ▸ | FNTB | P49356 | 3/20 | 0.52 |
| ▸ | CDC25B | P30305 | 5/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.43 |
| ▸ | CDC25A | P30304 | 1/20 | 0.42 |
| ▸ | CDC25C | P30307 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.41 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22973012 | 1.00 | FNTA (0.52) | FNTAFNTBCDC25BPGGT1BCDC25A | |
| SCHEMBL22973017 | 0.78 | CDC25B (0.49) | CDC25BCDC25ACDC25CNPC1RAB9A | |
| SCHEMBL22973000 | 0.76 | ALDH1A1 (0.53) | CDC25BCDC25ACDC25CNPC1RAB9A | |
| SCHEMBL3128229 | 0.75 | FNTA (0.39) | FNTAFNTBPGGT1B | |
| SCHEMBL22973010 | 0.74 | KDM4E (0.56) | FNTAFNTBPGGT1BMMP2 | |
| SCHEMBL22973009 | 0.74 | KDM4E (0.56) | FNTAFNTBPGGT1BMMP2 | |
| SCHEMBL11290401 | 0.74 | CDC25B (0.58) | CDC25BCDC25ACDC25CNPC1RAB9A | |
| SCHEMBL11315901 | 0.73 | RXFP1 (0.54) | CDC25BCDC25ACDC25CNPC1RAB9A | |
| SCHEMBL30000522 | 0.73 | RXFP1 (0.54) | CDC25BCDC25ACDC25CNPC1RAB9A | |
| SCHEMBL29209745 | 0.72 | ALDH1A1 (0.51) | CDC25BCDC25ACDC25CNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11905236-B2 | Dynamic combinatorial library based on pseudopeptides and its use for the detection of cysteine and other biothiols | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2024-02-20 | — | — | US | disclosed |
| EP-3779449-B1 | DYNAMIC COMBINATORIAL LIBRARY BASED ON PSEUDOPEPTIDES AND ITS USE FOR THE DETECTION OF CYSTEINE AND OTHER BIOTHIOLS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2022-02-23 | — | — | EP | disclosed |
| US-20210139419-A1 | DYNAMIC COMBINATORIAL LIBRARY BASED ON PSEUDOPEPTIDES AND ITS USE FOR THE DETECTION OF CYSTEINE AND OTHER BIOTHIOLS | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2021-05-13 | — | — | US | disclosed |
| EP-3779449-A2 | DYNAMIC COMBINATORIAL LIBRARY BASED ON PSEUDOPEPTIDES AND ITS USE FOR THE DETECTION OF CYSTEINE AND OTHER BIOTHIOLS | Consejo Superior de Investigaciones Cientificas (CSIC) (ES) | 2021-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139419-A1 | DYNAMIC COMBINATORIAL LIBRARY BASED ON PSEUDOPEPTIDES AND ITS USE FOR THE DETECTION OF CYSTEINE AND OTHER BIOTHIOLS | PTMS, LNPEP, CTH | FNTA 1363/4885FNTB 1796/4885CDC25B 1321/4885 |
| US-11905236-B2 | Dynamic combinatorial library based on pseudopeptides and its use for the detection of cysteine and other biothiols | PTMS, LNPEP, CTH | FNTA 1363/4885FNTB 1796/4885CDC25B 1321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.